Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Belantamab mafodotin-blmf

Drug name(s)

Blenrep Belantamab mafodotin-blmf

Approved for

  • Myeloma

Belinostat

Drug name(s)

Beleodaq™ Belinostat

Approved for

  • Lymphoma
  • Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS)

Belumosudil

Drug name(s)

Rezurock™ Belumosudil

Approved for

  • Other Blood Cancers

Bendamustine hydrochloride

Drug name(s)

Treanda® Bendamustine hydrochloride Bendeka™

Approved for

  • Lymphoma

Bexarotene

Drug name(s)

Targretin® Bexarotene

Approved for

  • Lymphoma
  • Cutaneous T-cell Lymphoma (CTCL)
  • Other Blood Cancers

Bleomycin

Drug name(s)

Blenoxane® Bleomycin

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)

Blinatumomab

Drug name(s)

Blincyto® Blinatumomab

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Bortezomib

Drug name(s)

Velcade® Bortezomib

Approved for

  • Lymphoma
  • Mantle Cell Lymphoma (MCL) 
  • Myeloma

Bosutinib

Drug name(s)

Bosulif® Bosutinib

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Brentuximab vedotin

Drug name(s)

Adcetris® Brentuximab vedotin

Approved for

  • Leukemia
  • T-Cell Prolymphocytic Leukemia
  • Hodgkin Lymphoma (HL)
  • Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS)
  • Other Blood Cancers

Brexucabtagene autoleucel

Drug name(s)

Tecartus® Brexucabtagene autoleucel

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Mantle Cell Lymphoma (MCL) 

Busulfan

Drug name(s)

Busulfex® Myleran® Busulfan

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Carmustine

Drug name(s)

BiCNU® BCNU Carmustine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)
  • Myeloma

Inotuzumab Ozogamicin

Drug name(s)

Besponsa® Inotuzumab Ozogamicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Lisocabtagene maraleucel

Drug name(s)

Breyanzi® Lisocabtagene maraleucel

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Follicular Lymphoma (FL) 
  • Mantle Cell Lymphoma (MCL) 

Ropeginterferon alfa-2b-njft

Drug name(s)

Ropeginterferon alfa-2b-njft Besremi®

Approved for

  • Polycythemia Vera

Sonrotoclax

Drug name(s)

Sonrotoclax Beqalzi™

Approved for

  • Mantle Cell Lymphoma (MCL) 

Zanubrutinib

Drug name(s)

Brukinsa® Zanubrutinib

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Follicular Lymphoma (FL) 
  • Mantle Cell Lymphoma (MCL) 
  • Marginal Zone Lymphoma (MZL) 
  • Waldenström Macroglobulinemia (WM)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.